704256006: Vedolizumab (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Immunosuppressant (substance)\Vedolizumab
\Drug or medicament (substance)\Monoclonal antibody\Vedolizumab

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Vedolizumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Vedolizumab

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Vedolizumab
\Biological substance\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Vedolizumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3011048012 Vedolizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3011945013 Vedolizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

67461000195112 Vedolizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

849061000172112 védolizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

53291000195115 vedolizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Vedolizumab	Is a	agent d'anticorps monoclonal	false	Inferred relationship	Some
Vedolizumab	Is a	Alpha-4 integrin receptor antagonist	true	Inferred relationship	Some
Vedolizumab	Is a	Monoclonal antibody	true	Inferred relationship	Some
Vedolizumab	Has disposition (attribute)	Alpha-4 integrin receptor antagonist (disposition)	true	Inferred relationship	Some
Vedolizumab	Has disposition (attribute)	Immunomodulator (disposition)	true	Inferred relationship	Some
Vedolizumab	Is a	anticorps monoclonal chimérique souris-humain d'isotype IgG	false	Inferred relationship	Some
Vedolizumab	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has active ingredient	False	Vedolizumab	Inferred relationship	Some
Product containing vedolizumab (medicinal product)	Has active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Product containing only vedolizumab (medicinal product)	Has active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab therapy (procedure)	Direct substance	True	Vedolizumab	Inferred relationship	Some	1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab-containing product in parenteral dose form	Has active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Product containing only vedolizumab in parenteral dose form (medicinal product form)	Has active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 158.824 mg/mL solution for injection	Has precise active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 158.824 mg/mL solution for injection	Has basis of strength substance (attribute)	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 300 mg powder for solution for infusion vial	Has precise active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 300 mg powder for solution for infusion vial	Has basis of strength substance (attribute)	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 300 mg powder for solution for infusion and/or injection vial	Has precise active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 300 mg powder for solution for infusion and/or injection vial	Has basis of strength substance (attribute)	True	Vedolizumab	Inferred relationship	Some	1

This concept is not in any reference sets